| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |